On Thursday (August 16), Summit Therapeutics was awarded an additional US$12 million bringing its total to US$44 million in gross committed funding from a Biomedical Advanced Research and Development Authority (BARDA) contract.
The post Summit Awarded Additional US$12 Million from BARDA appeared first on Investing News Network.
Original Article: Summit Awarded Additional US$12 Million from BARDA